Clinical Outcomes and Predictive Factors for Response after the First Course of Corticosteroid Therapy in Patients with Crohn’s Disease

키워드

참고문헌 (35)

1. Podolsky DK, "Inflammatory bowel disease", N Engl J Med, 325, pp.1008~1016 (1991)
2. Truelove SC, "Cortisone in ulcerative colitis: preliminary report on a therapeutic trial", Br Med J, 2, pp.375~378 (1954)
3. Summers RW, "National Cooperative Crohn’s Disease Study: results of drug treatment", Gastroenterology, 77(4 Pt 2), pp.847~869 (1979)
4. Malchow H, "European Cooperative Crohn’s Disease Study (ECCDS): results of drug treatment", Gastroenterology, 86, pp.249~266 (1984)
5. Greenberg GR, "Oral budesonide for active Crohn’s disease. Canadian Inflammatory Bowel Disease Study Group", N Engl J Med, 331, pp.836~841 (1994)
6. Caesar I, "Treatment of active and postactive ileal and colonic Crohn’s disease with oral pH-modified-release budesonide. German Budesonide Study Group", Hepatogastroenterology, 44, pp.445~451 (1997)
7. Campieri M, "Oral budesonide is as effective as oral prednisolone in active Crohn’s disease. The Global Budesonide Study Group", Gut, 41, pp.209~214 (1997)
8. Thomsen OO, "A comparison of budesonide and mesalamine for active Crohn’s disease. International Budesonide-Mesalamine Study Group", N Engl J Med, 339, pp.370~374 (1998)
9. Rutgeerts P, "A comparison of budesonide with prednisolone for active Crohn’s disease", N Engl J Med, 331, pp.842~845 (1994)
10. Faubion WA Jr, "The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study", Gastroenterology, 121, pp.255~260 (2001)
11. Steinhart AH, "Corticosteroids for maintenance of remission in Crohn’s disease", Cochrane Database Syst Rev, (4), pp.CD000301~ (2003)
12. "Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: A KASID study", INFLAMMATORY BOWEL DISEASES, 14, pp.542~549 (2008), JOHN WILEY & SONS INC
13. Ye BD, "Clinical features and long-term prognosis of Crohn’s disease in Korea", Scand J Gastroenterol, 45, pp.1178~1185 (2010)
14. Jiang L, "Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China", Inflamm Bowel Dis, 12, pp.212~217 (2006)
15. Leong RW, "The epidemiology and phenotype of Crohn’s disease in the Chinese population", Inflamm Bowel Dis, 10, pp.646~651 (2004)
16. Iida M, "Long-term follow-up study of Crohn’s disease in Japan. The Research Committee of Inflammatory Bowel Disease in Japan", J Gastroenterol, (30 Suppl 8), pp.17~19 (1995)
17. Papi C, "Long-term outcome of Crohn’s disease following corticosteroid-induced remission", Am J Gastroenterol, 102, pp.814~819 (2007)
18. Munkholm P, "Frequency of glucocorticoid resistance and dependency in Crohn’s disease", Gut, 35, pp.360~362 (1994)
19. Stange EF, "European evidence based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis", Gut, (55 Suppl 1), pp.i1~i15 (2006)
20. Sandborn WJ, "A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn’s disease", Gastroenterology, 122, pp.512~530 (2002)
21. Gasche C, "A simple classification of Crohn’s disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998", Inflamm Bowel Dis, 6, pp.8~15 (2000)
22. Yang YX, "Corticosteroids in Crohn’s disease", Am J Gastroenterol, 97, pp.803~823 (2002)
23. Irving PM, "Review article: appropriate use of corticosteroids in Crohn’s disease", Aliment Pharmacol Ther, 26, pp.313~329 (2007)
24. Michetti P, "Severe and steroid-resistant Crohn’s disease", Digestion, 76, pp.99~108 (2007)
25. Navarro FA, "Effect of long-term low-dose prednisone on height velocity and disease activity in pediatric and adolescent patients with Crohn disease", J Pediatr Gastroenterol Nutr, 45, pp.312~318 (2007)
26. Krupnick AS, "The long-term results of resection and multiple resections in Crohn’s disease", Semin Gastrointest Dis, 11, pp.41~51 (2000)
27. Inoue N, "Lack of common NOD2 variants in Japanese patients with Crohn’s disease", Gastroenterology, 123, pp.86~91 (2002)
28. Croucher PJ, "Haplotype structure and association to Crohn’s disease of CARD15 mutations in two ethnically divergent populations", Eur J Hum Genet, 11, pp.6~16 (2003)
29. Yang SK, "Association of TNFSF15 with Crohn’s disease in Koreans", Am J Gastroenterol, 103, pp.1437~1442 (2008)
30. Yamazaki K, "Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn’s disease", Hum Mol Genet, 14, pp.3499~3506 (2005)
31. Benchimol EI, "Traditional corticosteroids for induction of remission in Crohn’s disease", Cochrane Database Syst Rev, (2), pp.CD006792~ (2008)
32. Boirivant M, "The clinical significance of serum C reactive protein levels in Crohn’s disease. Results of a prospective longitudinal study", J Clin Gastroenterol, 10, pp.401~405 (1988)
33. Brignola C, "A laboratory index for predicting relapse in asymptomatic patients with Crohn’s disease", Gastroenterology, 91, pp.1490~1494 (1986)
34. Jarnum S, "Fecal radioiodide excretion following intravenous injection of 131-I-albumin and 125-I-immunoglobulin G in chronic inflammatory bowel disease. An aid to topographic diagnosis", Gastroenterology, 68, pp.1433~1444 (1975)
35. Hyun JG, "Analysis of clinical, biochemical and pathologic factors according to the response to initial steroid therapy in active Crohn’s disease", Korean J Gastrointest Endosc, 22, pp.406~410 (2001)

관련 논문AI추천